Drug information for MACUGEN

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
INJECTABLE; INTRAVITREAL EQ 0.3MG ACID/0.09ML Prescription  (Reference Drug) PEGAPTANIB SODIUM pegaptanib EYETECH INC 21756
2011-10-20 Label

2011-10-14 Letter

2006-03-23 Letter

2006-03-10 Label

2006-03-10 Label

2005-11-18 Letter

2005-11-18 Letter

2005-03-28 Review

2004-12-30 Letter

2004-12-30 Label

Drug Adverse Effects information for MACUGEN

Role code Indications Reaction # Reports
PS AGE-RELATED MACULAR DEGENERATION BLOOD PRESSURE SYSTOLIC INCREASED 2
PS AGE-RELATED MACULAR DEGENERATION CEREBRAL INFARCTION 2
PS AGE-RELATED MACULAR DEGENERATION CHEST PAIN 2
PS AGE-RELATED MACULAR DEGENERATION DEATH 1
PS AGE-RELATED MACULAR DEGENERATION UNEVALUABLE EVENT 1
PS AGE-RELATED MACULAR DEGENERATION VISUAL ACUITY REDUCED 1
PS AGE-RELATED MACULAR DEGENERATION VITREOUS HAEMORRHAGE 1
PS CHOROIDAL NEOVASCULARISATION CEREBRAL INFARCTION 1
PS MACULAR OEDEMA GASTRITIS 1
PS MACULAR OEDEMA INTRAOCULAR PRESSURE INCREASED 2
PS RETINAL VEIN OCCLUSION DRUG INEFFECTIVE 1
PS RETINAL VEIN OCCLUSION DYSPHAGIA 1
PS RETINAL VEIN OCCLUSION HYPERTENSION 1
PS RETINAL VEIN OCCLUSION INJECTION SITE DISCHARGE 1
PS RETINAL VEIN OCCLUSION LOCAL SWELLING 1
PS RETINAL VEIN OCCLUSION OCULAR DISCOMFORT 1
Ads by Google